Enovis Corporation Stock

Equities

ENOV

US1940145022

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 09:39:25 2024-06-10 am EDT 5-day change 1st Jan Change
45.16 USD -2.58% Intraday chart for Enovis Corporation -7.80% -17.26%
Sales 2024 * 2.13B Sales 2025 * 2.28B Capitalization 2.54B
Net income 2024 * -74M Net income 2025 * 54M EV / Sales 2024 * 1.78 x
Net Debt 2024 * 1.23B Net Debt 2025 * 1.21B EV / Sales 2025 * 1.65 x
P/E ratio 2024 *
-43.3 x
P/E ratio 2025 *
43.9 x
Employees 6,550
Yield 2024 *
-
Yield 2025 *
-
Free-Float 94.21%
More Fundamentals * Assessed data
Dynamic Chart
1 day-3.22%
1 week-7.80%
Current month-7.80%
1 month-9.21%
3 months-25.23%
6 months-6.42%
Current year-17.26%
More quotes
1 week
46.00
Extreme 46
48.77
1 month
46.00
Extreme 46
53.84
Current year
46.00
Extreme 46
65.03
1 year
43.04
Extreme 43.04
66.14
3 years
43.04
Extreme 43.04
164.01
5 years
36.69
Extreme 36.69
164.01
10 years
36.69
Extreme 36.69
225.78
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 15-07-23
Director of Finance/CFO 45 19-12-31
Director/Board Member 58 18-12-31
Members of the board TitleAgeSince
Director/Board Member 57 22-04-03
Director/Board Member 53 08-05-12
Director/Board Member 62 16-06-14
More insiders
Date Price Change Volume
24-06-07 46.35 -3.22% 416 433
24-06-06 47.89 -0.40% 554,622
24-06-05 48.08 +1.29% 634,047
24-06-04 47.47 -3.44% 934,372
24-06-03 49.16 -2.21% 480,205

Delayed Quote Nyse, June 07, 2024 at 04:00 pm EDT

More quotes
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
46.35 USD
Average target price
74.1 USD
Spread / Average Target
+59.87%
Consensus